LEADER 04056nam 22005535 450 001 9910299284003321 005 20200705033617.0 010 $a3-319-77794-7 024 7 $a10.1007/978-3-319-77794-8 035 $a(CKB)3810000000358760 035 $a(MiAaPQ)EBC5446663 035 $a(DE-He213)978-3-319-77794-8 035 $a(PPN)229497470 035 $a(EXLCZ)993810000000358760 100 $a20180627d2018 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aWeb Content Credibility /$fby Adam Wierzbicki 205 $a1st ed. 2018. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018. 215 $a1 online resource (225 pages) 311 $a3-319-77793-9 327 $a1 Introduction -- 2 Understanding and Measuring Credibility -- 3 Supporting Online Credibility Evaluation -- 4 Credibility of Social Media -- 5 Theoretical Models of Credibility -- 6 Conclusions. 330 $aThis book introduces readers to Web content credibility evaluation and evaluation support. It highlights empirical research and establishes a solid foundation for future research by presenting methods of supporting credibility evaluation of online content, together with publicly available datasets for reproducible experimentation, such as the Web Content Credibility Corpus. The book is divided into six chapters. After a general introduction in Chapter 1, including a brief survey of credibility evaluation in the social sciences, Chapter 2 presents definitions of credibility and related concepts of truth and trust. Next, Chapter 3 details methods, algorithms and user interfaces for systems supporting Web content credibility evaluation. In turn, Chapter 4 takes a closer look at the credibility of social media, exemplified in sections on Twitter, Q&A systems, and Wikipedia, as well as fake news detection. In closing, Chapter 5 presents mathematical and simulation models of credibility evaluation, before a final round-up of the book is provided in Chapter 6. Overall, the book reviews and synthesizes the current state of the art in Web content credibility evaluation support and fake news detection. It provides researchers in academia and industry with both an incentive and a basis for future research and development of Web content credibility evaluation support services. Misinformation on the Internet, deliberate or merely out of ignorance, is a serious problem and it puts users in the position of needing strong critical thinking skills to sort wheat from chaff. This book will help. It's an impressive exploration of ideas in the area of Web content credibility evaluation support. ? Vint Cerf, Vice President and Chief Internet Evangelist at Google. 606 $aApplication software 606 $aUser interfaces (Computer systems) 606 $aMultimedia systems  606 $aSoftware engineering 606 $aInformation Systems Applications (incl. Internet)$3https://scigraph.springernature.com/ontologies/product-market-codes/I18040 606 $aUser Interfaces and Human Computer Interaction$3https://scigraph.springernature.com/ontologies/product-market-codes/I18067 606 $aMedia Design$3https://scigraph.springernature.com/ontologies/product-market-codes/I25004 606 $aSoftware Engineering$3https://scigraph.springernature.com/ontologies/product-market-codes/I14029 615 0$aApplication software. 615 0$aUser interfaces (Computer systems). 615 0$aMultimedia systems . 615 0$aSoftware engineering. 615 14$aInformation Systems Applications (incl. Internet). 615 24$aUser Interfaces and Human Computer Interaction. 615 24$aMedia Design. 615 24$aSoftware Engineering. 676 $a006.7 700 $aWierzbicki$b Adam$4aut$4http://id.loc.gov/vocabulary/relators/aut$0859928 906 $aBOOK 912 $a9910299284003321 996 $aWeb Content Credibility$91918850 997 $aUNINA LEADER 02133nam 22006492 450 001 9910955538803321 005 20240912171150.0 010 $a0-19-773464-2 010 $a9786610453245 010 $a1-280-45324-9 010 $a1-4237-4131-5 010 $a0-19-802697-8 024 7 $a10.1093/oso/9780195109863.001.0001 035 $a(CKB)24235118200041 035 $a(NjHacI)9924235118200041 035 $a(MiAaPQ)EBC241371 035 $a(OCoLC)1406783995 035 $a(StDuBDS)9780197734643 035 $a(MiAaPQ)EBC7037622 035 $a(OCoLC)813738977 035 $a(FINmELB)ELB164880 035 $a(Au-PeEL)EBL7037622 035 $a(OCoLC)1336403690 035 $a(EXLCZ)9924235118200041 100 $a19980511e20231998 fy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aApes, language, and the human mind /$fSue Savage-Rumbaugh, Stuart G. Shanker, Talbot J. Taylor 210 $aNew York $cOxford University Press$d1998 210 1$aNew York ;$cOxford University Press,$d2023. 215 $a1 online resource (x, 244 pages) $cillustrations 225 1 $aOxford scholarship online 300 $aPreviously issued in print: 1998. 320 $aIncludes bibliographical references (pages 233-240) and index. 330 8 $aThis text presents the findings of Sue Savage-Rumbaugh into the linguistic and cognitive skills of a number of laboratory-based primates. 410 0$aOxford scholarship online. 606 $aPrimates$xPsychology 606 $aCognitive learning 606 $aAnimal communication 615 0$aPrimates$xPsychology. 615 0$aCognitive learning. 615 0$aAnimal communication. 676 $a599.8851594 700 $aSavage-Rumbaugh$b E. Sue$01860400 702 $aShanker$b Stuart 702 $aTaylor$b Talbot J. 801 0$bStDuBDS 801 1$bStDuBDS 801 2$bStDuBDSZ 801 2$bStDuBDSZ 906 $aBOOK 912 $a9910955538803321 996 $aApes, language, and the human mind$94465273 997 $aUNINA LEADER 04853nam 2200853Ia 450 001 9910958947303321 005 20251017110114.0 010 $a9786611767525 010 $a9780309185691 010 $a0309185696 010 $a9781281767523 010 $a1281767522 010 $a9780309118675 010 $a0309118670 035 $a(CKB)2550000000004405 035 $a(EBL)3378374 035 $a(SSID)ssj0000288925 035 $a(PQKBManifestationID)11220286 035 $a(PQKBTitleCode)TC0000288925 035 $a(PQKBWorkID)10383139 035 $a(PQKB)10130252 035 $a(MiAaPQ)EBC3378374 035 $a(Au-PeEL)EBL3378374 035 $a(CaPaEBR)ebr10237094 035 $a(CaONFJC)MIL176752 035 $a(OCoLC)923279005 035 $a(Perlego)4740388 035 $a(DNLM)1480731 035 $a(BIP)21074671 035 $a(EXLCZ)992550000000004405 100 $a20080521d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAntivirals for pandemic influenza $eguidance on developing a distribution and dispensing program /$fCommittee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies 205 $a1st ed. 210 $aWashington, DC $cNational Academies Press$dc2008 215 $a1 online resource (x, 122 pages) 300 $aDescription based upon print version of record. 311 08$aPrint version: Institute of Medicine (U.S.). Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic. Antivirals for pandemic influenza. Washington, DC : National Academies Press, ©2008 9780309118668 (DLC) 2008298577 (OCoLC)228498016 311 08$a9780309118668 311 08$a0309118662 320 $aIncludes bibliographical references. 327 $aIntroduction -- Antiviral effectiveness, safety, and supply -- Ethics, decision making, and communication -- Who should get antivirals and where? 330 $aPlanning for an influenza pandemic, whether it occurs in the near or distant future, will need to take into account many constantly evolving factors. The Institute of Medicine (IOM) Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic was asked by the Department of Health and Human Services, (DHHS) to consider best practices and policies for providing antiviral treatment and prophylaxis during a pandemic event. The committee (TM)s report, entitled Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program, calls for a national and public process of creating an ethical framework for antiviral use within the context of uncertainty and scarcity. It is unclear whether antivirals will work against a pandemic strain as well as they work against seasonal influenza. Also, government stockpiles may not be sufficient for all possible uses in part because antivirals are costly and public health agencies must invest in other important activities, including other medical resources for pandemic influenza. Furthermore, the report identifies the lack of a science-based advisory body to guide decision making during the pandemic, including guidance on all dimensions of antiviral dispensing (for example, prioritization, drug safety, and antiviral resistance). The report also acknowledges the need for diverse methods and sites of dispensing, and discusses their advantages and disadvantages. 606 $aAntiviral agents$xEffectiveness 606 $aAntiviral agents 606 $aEpidemics$xPrevention 606 $aInfluenza$xPrevention 606 $aInfluenza, Human$xprevention & control$3(DNLM)D007251Q000517 606 $aAntiviral Agents$xsupply & distribution$3(DNLM)D000998Q000600 606 $aProgram Development$xmethods$3(DNLM)D016730Q000379 606 $aAntiviral Agents$xtherapeutic use$3(DNLM)D000998Q000627 606 $aDisease Outbreaks$xprevention & control$3(DNLM)D004196Q000517 615 0$aAntiviral agents$xEffectiveness. 615 0$aAntiviral agents. 615 0$aEpidemics$xPrevention. 615 0$aInfluenza$xPrevention. 615 12$aInfluenza, Human$xprevention & control. 615 12$aAntiviral Agents$xsupply & distribution. 615 12$aProgram Development$xmethods. 615 22$aAntiviral Agents$xtherapeutic use. 615 22$aDisease Outbreaks$xprevention & control. 676 $a614.518 712 02$aInstitute of Medicine (U.S.).$bBoard on Population Health and Public Health Practice. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910958947303321 996 $aAntivirals for pandemic influenza$94365666 997 $aUNINA